Need to report a covid-19 positive test or exposure? Click here

Covid-19 Vaccine Information

Auburn is actively planning to distribute COVID-19 vaccines to the campus community in collaboration with state public health officials. As it becomes available, information about Auburn’s COVID-19 vaccine allocation and distribution plan will be posted on this page.

View and submit vaccination request form

View the vaccination allocation guidelines

Vaccine availability

Auburn is expected to receive enough vaccine doses for the entire campus community, distributing them using a phased approach.

If interested, individuals are encouraged to promptly submit the Covid-19 Vaccination Reservation Form.

Individuals who wish to be vaccinated for COVID-19 are encouraged to take any opportunities to register or receive the vaccine that may be available to them, such as through health care providers or public health programs, in addition to registering through Auburn.

0
Vaccine Doses Received
0
Vaccine Doses Administered
as of Jan. 22, 2021
Vaccination Program Phases

The university is taking a phased approach to vaccine distribution. Currently, the university is in phase 1c.

Phase 1A
  • Individuals serving in a healthcare setting who have the potential for direct or indirect exposure to patients or infectious materials and are unable to work remotely.

  • Campus first responders.

Phase 1B
  • Individuals 1) who are required to be on campus to perform their job duties, AND 2) who are unable to consistently maintain physical distancing while at work due to job responsibilities, AND 3) who have a high-risk medical condition as specified by the CDC and/or are age 65 or older.

Phase 1C
  • Individuals 1) who are required to be on campus to perform their job duties, AND 2) who are unable to consistently maintain physical distancing while at work due to job responsibilities

  • Other adults with high-risk medical condition as specified by the CDC and/or are age 65 or older that do not fall under 1b.

  • Designated student population involved in remote or off-campus clinical settings, including internships and practicums that involve direct human contact.

Phase 2
  • All individuals not included in Phase 1a, 1b or 1c as vaccine becomes available.

Phase 3
  • Family members and dependents of employees as vaccine becomes available.

  • Members of the local community as vaccine becomes available.

Last updated: January 23, 2021